United Therapeutics Corpo... (UTHR)
NASDAQ: UTHR
· Real-Time Price · USD
320.44
4.80 (1.52%)
At close: May 29, 2025, 3:59 PM
320.37
-0.02%
After-hours: May 29, 2025, 04:27 PM EDT
1.52% (1D)
| Bid | 310 |
| Market Cap | 14.45B |
| Revenue (ttm) | 2.99B |
| Net Income (ttm) | 1.21B |
| EPS (ttm) | 25.09 |
| PE Ratio (ttm) | 12.77 |
| Forward PE | 10.69 |
| Analyst | Buy |
| Ask | 322.06 |
| Volume | 356,090 |
| Avg. Volume (20D) | 476,781 |
| Open | 315.77 |
| Previous Close | 315.64 |
| Day's Range | 311.62 - 320.54 |
| 52-Week Range | 266.98 - 417.82 |
| Beta | 0.58 |
About UTHR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UTHR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for UTHR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-10.8%
United Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
9 months ago
+3.04%
United Therapeutics shares are trading higher after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $400 to $572.
4 weeks ago · seekingalpha.com
United Therapeutics Corporation (UTHR) Q1 2025 Earnings Call TranscriptUnited Therapeutics Corporation (NASDAQ:UTHR ) Q1 2025 Earnings Conference Call April 30, 2025 9:00 AM ET Company Participants Dewey Steadman - Head of Investor Relations Martine Rothblatt - Chairpers...
